Oct 2026· Science China Life Sciences· 0 citations· 212 references
Medicine
TL;DR
A deeper understanding of cell type-specific inflammatory circuits and cytokine interactions will be essential for developing rational combination therapies to overcome microenvironment-driven resistance.
Acute myeloid leukemia (AML) is an aggressive clonal myeloid malignancy characterized by the expansion of differentiation-arrested blasts. Treatment resistance, measurable residual disease, and relapse remain major causes of treatment failure. Experimental and clinical evidence indicates that the bone marrow microenvir...
Wen-Hao Xu, Qing-Lian Han, Chang-Rong Sun et al.· Frontiers in Oncology· 0 citations
Tumor drug resistance is still the core obstacle limiting the long-term benefit of modern anticancer therapy, especially in the context of treatment tolerance, persistence of minimal residual disease (MRD) and recurrence after treatment. Increasing evidence has shown that therapy-associated myeloid niches can involve c...
Ting Li, Yan-Xia Lin, Q. Gang et al.· Cancer Letters· 0 citations
The mechanisms underlying immune dysregulation in MM are discussed, recent discoveries regarding immune remodeling associated with clinical outcomes are summarized, and the translational implications of immune-based biomarkers and therapeutic strategies are explored.
Maria P. Ghirardi, Patrícia Brandalise, M. Berraondo et al.· Immuno· 0 citations
The mechanisms governing MDSCs interactions within the myeloma TME are elucidated, potential therapeutic strategies targeting MDSCs are discussed, and a rational framework for integrating MDSC-directed approaches with current MM therapies and immunotherapy is outlined.
Jing-Jing Wen, Qiao-Lin Zhou, Jing Yue et al.· Frontiers in Immunology· 0 citations
The tumor microenvironment (TME) is increasingly recognized as a dynamic and biologically active ecosystem that profoundly influences cancer initiation, progression, metastasis, immune escape, and therapeutic resistance. Rather than functioning as an isolated mass of malignant cells, a tumor consists of complex interac...
Drishti Singla, Sahil Singhal, Samanvaya Sharma et al.· International Journal of Dru...· 0 citations
Acute myeloid leukemia (AML) relapse and drug resistance remain major causes of mortality in hematologic malignancies, driven in part by CXCR4/CXCL12-mediated homing and retention of leukemic cells within the bone marrow niche, as well as immune evasion mechanisms that enable their persistent survival. Here, we report...
Fei Wang, Qian-Qian Li, Yan Wang et al.· Acta Biomaterialia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.